If you were unable to attend the live event on December 9, we invite you to join us for an exclusive Zoom replay of the 2025 Accelerating BioVenture Innovation (ABI ) Final Pitch Competition.

This event showcases five exceptional teams of Tri-I researchers and clinicians as they present novel biomedical technologies and their proposed commercialization strategies. The presentations were evaluated by a distinguished panel of venture capital and industry leaders, including representatives from Pfizer Ventures, Octagon Capital Advisors and Panacea Venture, offering insight into how investors and industry partners view academic innovations.

We hope you will join us for this engaging and informative showcase of faculty-initiated entrepreneurship at Weill Cornell Medicine.

RSVP here.